IDEXX Laboratories Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, IDEXX Laboratories stock has a consensus rating of "Buy" and an average price target of $717.17. The average 1-year stock price forecast is 2.95% higher than the current stock price, while the lowest is $470 (-32.53%) and the highest is $810 (+16.27%).

Price Target: $717.17 (+2.95%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$470	$717.17	$717.5	$810
Change	-32.53%	+2.95%	+2.99%	+16.27%

Analyst Ratings

The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	5	5	4	4	5	5
Buy	4	4	4	4	4	4
Hold	5	5	5	4	4	4
Sell	1	1	1	1	1	0
Strong Sell	0	0	0	0	0	1
Total	15	15	14	13	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Block Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $675 → $700	Buy	Maintains	$675 → $700	+0.48%	Nov 4, 2026
Keith Devas Jefferies	Jefferies	Buy Reiterates $705 → $770	Buy	Reiterates	$705 → $770	+10.53%	Nov 3, 2026
Erin Wright Morgan Stanley	Morgan Stanley	Buy Maintains $805 → $810	Buy	Maintains	$805 → $810	+16.27%	Nov 3, 2026
Andrea Alfonso UBS	UBS	Hold Reiterates $627 → $700	Hold	Reiterates	$627 → $700	+0.48%	Nov 3, 2026
Chris Schott J.P. Morgan	J.P. Morgan	Buy Reiterates $775 → $750	Buy	Reiterates	$775 → $750	+7.66%	Oct 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.75B

from 4.30B

10.43%

from 4.30B

Revenue Next Year

5.17B

from 4.75B

8.87%

from 4.75B

EPS This Year

15.00

from 13.08

14.67%

from 13.08

EPS Next Year

16.88

from 15.00

12.56%

from 15.00

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.22B	3.37B	3.66B	3.90B	4.30B	4.75B
Revenue Growth	18.80%	4.73%	8.72%	6.46%	10.42%	10.43%
Gross Profit	1.89B	2.00B	2.19B	2.38B	2.66B	2.98B
Gross Margin	58.76%	59.52%	59.82%	61.04%	61.80%	62.80%
Operating Income	932.03M	898.77M	1.10B	1.19B	1.36B	1.53B
Net Income	744.85M	679.09M	845.04M	887.87M	1.06B	1.19B
EPS	-	-	-	-	13.08	15.00
EPS Growth	-	-	-	-	22.59%	14.67%
Forward PE	73.77	44.25	51.93	35.35	48.03	46.45
Free Cash Flow	-	-	-	-	1.06B	1.17B
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	4.8B
Avg	4.8B
Low	4.7B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	10.9%
Avg	10.4%
Low	9.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	15.13
Avg	15.00
Low	14.65

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	15.7%
Avg	14.7%
Low	12.0%